-
Ertapenem, sold
under the
brand name Invanz, is a
carbapenem antibiotic medication used for the
treatment of
infections of the abdomen, the lungs, the...
-
Ceftobiprole (Broadest
spectrum of β-lactam antibiotics)
Biapenem Doripenem Ertapenem Faropenem Imipenem Meropenem Panipenem Razupenem Tebipenem Thienamycin...
- combinations: Carbapenems: (meropenem, imipenem/cilastatin,
doripenem - NOT
ertapenem) Meropenem/vaborbactam Imipenem/cilastatin/relebactam Others: Fluoroquinolones:...
-
carbapenems cover Gram-positives, Gram-negatives, and
anaerobes except for
ertapenem. The only
fluoroquinolone that can be used is
moxifloxacin because this...
-
pneumoniae and
other carbapenem-resistant Enterobacteriaceae). The
carbapenem ertapenem is one of
several first-line
agents recommended by the
Infectious Disease...
- once-daily
ertapenem for the
treatment of cIAI. A
total of 541
patients were
included and
eravacycline demonstrated noninferiority to
ertapenem. An additional...
-
intravenous ertapenem therapy showed clinical improvement with 80.3% of
subjects reporting medium to high
satisfaction and 90.8%
would recommend ertapenem to other...
- penicillins, cephalosporins, cephamycins,
monobactams and
carbapenems (
ertapenem),
although carbapenems are
relatively resistant to beta-lactamase. Beta-lactamase...
-
further progression of
their disease in over 6
months of follow-up.
Invanz (
Ertapenem) is an
injectable antibiotic,
rights to
which Merck has
owned since 1999...
-
susceptibility patterns must be
taken into
account when
deciding on treatment.
Ertapenem is a
potential effective alternative treatment for ceftriaxone-resistant...
